Pramoxine Hydrochloride

CHEMBL1201171 Phase 4 ได้รับการอนุมัติ Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
329.9 g/mol
LogP
Phase
4

Pramoxine hydrochloride is the hydrochloride salt form of pramoxine, a topical local anesthetic that blocks sodium channels in sensory nerves to provide temporary relief of pain and pruritus in minor skin conditions and anorectal disorders. See pramoxine for complete pharmacological details.

น้ำหนักโมเลกุล

329.9000 g/mol

TPSA

30.90 Ų

กลไกการออกฤทธิ์

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

กลไก

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

โครงสร้าง 2 มิติ

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCCCOc1ccc(OCCCN2CCOCC2)cc1.Cl

InChI

InChI=1S/C17H27NO3.ClH/c1-2-3-12-20-16-5-7-17(8-6-16)21-13-4-9-18-10-14-19-15-11-18;/h5-8H,2-4,9-15H2,1H3;1H

Molecular Formula

C17H28ClNO3

HBD / HBA

1 / 4

พันธะที่หมุนได้

9

อะตอมหนัก

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

Pramoxine hydrochloride is the hydrochloride salt form of pramoxine, a topical local anesthetic that blocks sodium channels in sensory nerves to provide temporary relief of pain and pruritus in minor skin conditions and anorectal disorders. See pramoxine for complete pharmacological details.

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

Yes, Pramoxine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201171. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 73957. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.